A detailed history of Eudaimonia Partners, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Eudaimonia Partners, LLC holds 2,535 shares of DGX stock, worth $347,523. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,535
Previous 2,535 -0.0%
Holding current value
$347,523
Previous $349,000 3.44%
% of portfolio
0.08%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023

SELL
$130.56 - $146.84 $391 - $440
-3 Reduced 0.12%
2,535 $356,000
Q1 2023

Apr 25, 2023

BUY
$131.53 - $155.76 $394 - $467
3 Added 0.12%
2,538 $359,000
Q3 2022

Nov 03, 2022

SELL
$121.77 - $141.1 $7,306 - $8,466
-60 Reduced 2.31%
2,535 $311,000
Q2 2022

Aug 09, 2022

SELL
$127.07 - $145.39 $9,021 - $10,322
-71 Reduced 2.66%
2,595 $345,000
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $62,995 - $80,202
-488 Reduced 15.47%
2,666 $365,000
Q3 2021

Oct 25, 2021

SELL
$132.95 - $158.0 $39,087 - $46,452
-294 Reduced 8.53%
3,154 $458,000
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $29,131 - $32,540
230 Added 7.15%
3,448 $455,000
Q4 2020

Feb 18, 2021

SELL
$112.7 - $128.05 $1,014 - $1,152
-9 Reduced 0.28%
3,218 $383,000
Q3 2020

Nov 23, 2020

SELL
$107.05 - $130.01 $1.82 Million - $2.21 Million
-16,974 Reduced 84.03%
3,227 $369,000
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $1.83 Million - $2.22 Million
17,090 Added 549.34%
20,201 $804,000
Q2 2020

Aug 14, 2020

SELL
$73.34 - $122.61 $1,906 - $3,187
-26 Reduced 0.83%
3,111 $355,000
Q1 2020

May 05, 2020

SELL
$75.14 - $115.68 $450 - $694
-6 Reduced 0.19%
3,137 $252,000
Q4 2019

May 05, 2020

BUY
$100.29 - $107.99 $315,211 - $339,412
3,143 New
3,143 $336,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.